Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death

Antibodies that target immune checkpoint proteins such as programmed cell death protein 1, programmed death ligand 1, and cytotoxic T-lymphocyte–associated antigen 4 in human cancers have achieved impressive clinical success; however, a significant proportion of patients fail to respond to these tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Riyao, Sun, Linlin, Li, Ching-Fei, Wang, Yu-Han, Xia, Weiya, Liu, Boning, Chu, Yu-Yi, Bover, Laura, Vien, Long, Hung, Mien-Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006662/
https://www.ncbi.nlm.nih.gov/pubmed/35283189
http://dx.doi.org/10.1016/j.jbc.2022.101821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006662/
https://www.ncbi.nlm.nih.gov/pubmed/35283189
http://dx.doi.org/10.1016/j.jbc.2022.101821

Ejemplares similares